 "sun pharma")
Drug major Sun Pharmaceutical on Friday reported a 14 per cent decline in consolidated net profit at Rs 1,223 crore for the fourth quarter ended March 31, on account of pricing pressure in the US market. The company had reported a net profit of Rs 1,416 crore for the same period of previous financial year.
Income from operations during the period also declined to Rs 6,825 crore, as compared to Rs 7,415 crore in the same period of previous financial year, Sun Pharmaceutical Industries said in a statement.
For the year ended March 31, the company posted a consolidated net profit of
